BiomEdit Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $4.5M

  • Investors
  • 7

BiomEdit General Information

Description

Developer of microbiome innovation platform intended to discover and develop animal health products. The company's platform utilizes microbiome-derived bioactive and engineered microbial medicines to address unmet needs in animal health, enabling clients to improve animal protein production and livestock disease monitoring.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10100 Lantern Road
  • Suite 150
  • Fishers, IN 46037
  • United States
+1 (317)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 10100 Lantern Road
  • Suite 150
  • Fishers, IN 46037
  • United States
+1 (317)

BiomEdit Timeline

20232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BiomEdit Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 02-Nov-2023 $4.5M Completed Product Development
4. Early Stage VC (Series A2) 15-Feb-2023 Completed Product Development
3. Early Stage VC (Series A) 14-Apr-2022 Completed Startup
2. Accelerator/Incubator 11-Apr-2022 Completed Startup
1. Joint Venture 11-Apr-2022 Completed Startup
To view BiomEdit’s complete valuation and funding history, request access »

BiomEdit Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbiome innovation platform intended to discover and develop animal health products. The company's platf
Biotechnology
Fishers, IN
37 As of 2024

Paris, France
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BiomEdit Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eligo Bioscience Venture Capital-Backed Paris, France
Resilient Biotics Venture Capital-Backed Durham, NC
Xeno Biosciences Venture Capital-Backed Cambridge, MA
Prokaryotics Corporation Union, NJ
Bactolife Venture Capital-Backed Copenhagen, Denmark
You’re viewing 5 of 29 competitors. Get the full list »

BiomEdit Patents

BiomEdit Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4422653-A1 Probiotic lactobacillus strain compositions and applications therefor including for leaky gut and inflammation Pending 26-Oct-2021
EP-4404967-A1 Vhh antibodies targeting fimh and methods of using the same Pending 23-Sep-2021
EP-4387638-A1 Genetically modified bacillus subtilis strain and use as a live delivery and production system Pending 22-Sep-2021
EP-4404946-A1 Methods of inhibiting diseases caused by respiratory viruses Pending 22-Sep-2021
AU-2022350478-A1 Antimicrobial peptides Pending 21-Sep-2021 A61P31/04
To view BiomEdit’s complete patent history, request access »

BiomEdit Executive Team (4)

Name Title Board Seat
Bruce Schelkopf Chief IP Officer, General Counsel & Secretary
Eric Young Chief Business Officer
Aaron Schacht Founder, Chief Executive Officer & Board Member
Eric Bonabeau Chief Technology Officer
To view BiomEdit’s complete executive team members history, request access »

BiomEdit Board Members (5)

Name Representing Role Since
Aaron Schacht Self Founder, Chief Executive Officer & Board Member
Barbara Bodem Self Board Member
Brett Wong Anterra Capital Board Member
Patrick James Self Chairman
Paul Casady Self Board Member
To view BiomEdit’s complete board members history, request access »

BiomEdit Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiomEdit Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
Nutreco Corporation Minority
Anterra Capital Venture Capital Minority
Viking Global Investors Hedge Fund Minority
Elanco Animal Health Corporation Majority
You’re viewing 5 of 7 investors. Get the full list »

BiomEdit FAQs

  • When was BiomEdit founded?

    BiomEdit was founded in 2022.

  • Who is the founder of BiomEdit?

    Aaron Schacht is the founder of BiomEdit.

  • Who is the CEO of BiomEdit?

    Aaron Schacht is the CEO of BiomEdit.

  • Where is BiomEdit headquartered?

    BiomEdit is headquartered in Fishers, IN.

  • What is the size of BiomEdit?

    BiomEdit has 37 total employees.

  • What industry is BiomEdit in?

    BiomEdit’s primary industry is Biotechnology.

  • Is BiomEdit a private or public company?

    BiomEdit is a Private company.

  • What is BiomEdit’s current revenue?

    The current revenue for BiomEdit is .

  • How much funding has BiomEdit raised over time?

    BiomEdit has raised $36.5M.

  • Who are BiomEdit’s investors?

    Bill & Melinda Gates Foundation, Nutreco, Anterra Capital, Viking Global Investors, and Elanco Animal Health are 5 of 7 investors who have invested in BiomEdit.

  • Who are BiomEdit’s competitors?

    Eligo Bioscience, Resilient Biotics, Xeno Biosciences, Prokaryotics, and Bactolife are some of the 29 competitors of BiomEdit.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »